The Journal of Pain
Volume 11, Issue 1 , Pages 13-23 , January 2010

A Single Nitrous Oxide (N2O) Exposure Leads to Persistent Alleviation of Neuropathic Pain in Rats

  • Baptiste Bessière

      Affiliations

    • Université Bordeaux 2, Université Bordeaux 1, CNRS, UMR 5227, Bordeaux, France
    • Centre de Recherche Claude Delorme, Air Liquide, Jouy-en-Josas, France
    • ,
  • Emilie Laboureyras

      Affiliations

    • Université Bordeaux 2, Université Bordeaux 1, CNRS, UMR 5227, Bordeaux, France
    • ,
  • Jérémy Chateauraynaud

      Affiliations

    • Université Bordeaux 2, Université Bordeaux 1, CNRS, UMR 5227, Bordeaux, France
    • ,
  • Jean-Paul Laulin

      Affiliations

    • Université Bordeaux 2, Université Bordeaux 1, CNRS, UMR 5227, Bordeaux, France
    • ,
  • Guy Simonnet

      Affiliations

    • Université Bordeaux 2, Université Bordeaux 1, CNRS, UMR 5227, Bordeaux, France
    • Corresponding Author InformationAddress reprint requests to Dr Guy Simonnet, Université Bordeaux 2, Université Bordeaux 1, CNRS, UMR 5227, Team Homéostasie-Allostasie-Pathologie-Réhabilitation, 146 rue Léo Saignat 33076, Bordeaux, France.

Received 31 July 2008 ,Revised 6 March 2009 ,Accepted 19 May 2009.

References 

  1. Araujo MC, Sinnott CJ, Strichartz GR. Multiple phases of relief from experimental mechanical allodynia by systemic lidocaine: Responses to early and late infusions. Pain. 2003;103:21–29
  2. Arguis MJ, Perez J, Martinez G, Ubre M, Gomar C. Contralateral neuropathic pain following a surgical model of unilateral nerve injury in rats. Reg Anesth Pain Med. 2008;33:211–216
  3. Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13:1153–1169
  4. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107
  5. Berkowitz BA, Ngai SH, Finck AD. Nitrous oxide “analgesia”: Resemblance to opiate action. Science. 1976;194:967–968
  6. Bessiere B, Richebe P, Laboureyras E, Laulin JP, Contarino A, Simonnet G. Nitrous oxide (N(2)O) prevents latent pain sensitization and long-term anxiety-like behavior in pain and opioid-experienced rats. Neuropharmacology. 2007;53:733–740
  7. Bileviciute-Ljungar I, Biella G, Bellomi P, Sotgiu ML. Contralateral treatment with lidocaine reduces spinal neuronal activity in mononeuropathic rats. Neurosci Lett. 2001;311:157–160
  8. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287–333
  9. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006;52:77–92
  10. Célèrier E, Laulin J, Larcher A, Le Moal M, Simonnet G. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats. Brain Res. 1999;847:18–25
  11. Célèrier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, et al. Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology. 2000;92:465–472
  12. Chizh BA, Headley PM. NMDA antagonists and neuropathic pain: Multiple drug targets and multiple uses. Curr Pharm Des. 2005;11:2977–2994
  13. Chizh BA, Headley PM, Tzschentke TM. NMDA receptor antagonists as analgesics: Focus on the NR2B subtype. Trends Pharmacol Sci. 2001;22:636–642
  14. Christoph T, Schiene K, Englberger W, Parsons CG, Chizh BA. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism. Neuropharmacology. 2006;51:12–17
  15. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence. Pain. 1993;52:259–285
  16. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: A retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med. 2004;5:263–275
  17. Eisenberg E, Pud D. Can patients with chronic neuropathic pain be cured by acute administration of the NMDA receptor antagonist amantadine?. Pain. 1998;74:337–339
  18. Emmanouil DE, Quock RM. Advances in understanding the actions of nitrous oxide. Anesth Prog. 2007;54:9–18
  19. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain. 2005;118:289–305
  20. Fujinaga M, Maze M. Neurobiology of nitrous oxide-induced antinociceptive effects. Mol Neurobiol. 2002;25:167–189
  21. Georgiev SK, Kohno T, Ikoma M, Yamakura T, Baba H. Nitrous oxide inhibits glutamatergic transmission in spinal dorsal horn neurons. Pain. 2008;134:24–31
  22. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol. 2004;65:443–452
  23. Guilbaud G, Benoist JM, Jazat F, Gautron M. Neuronal responsiveness in the ventrobasal thalamic complex of rats with an experimental peripheral mononeuropathy. J Neurophysiol. 1990;64:1537–1554
  24. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med. 1998;4:460–463
  25. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: Do pain and memory share similar mechanisms?. Trends Neurosci. 2003;26:696–705
  26. Kayser V, Besson JM, Guilbaud G. Paradoxical hyperalgesic effect of exceedingly low doses of systemic morphine in an animal model of persistent pain (Freund's adjuvant- induced arthritic rats). Brain Res. 1987;414:155–157
  27. Kemp JA, McKernan RM. NMDA receptor pathways as drug targets. Nat Neurosci. 2002;5(Suppl):1039–1042
  28. Klein T, Magerl W, Hanschmann A, Althaus M, Treede RD. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia. Eur J Pain. 2008;12:17–29
  29. Koltzenburg M, Wall PD, McMahon SB. Does the right side know what the left is doing?. Trends Neurosci. 1999;22:122–127
  30. Mao J, Mayer DJ, Hayes RL, Price DD. Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy. J Neurophysiol. 1993;70:470–481
  31. Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, Zorumski CF. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci. 1998;18:9716–9726
  32. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci. 2003;23:1026–1040
  33. Nagele P, Metz LB, Crowder CM. Nitrous oxide (N(2)O) requires the N-methyl-D-aspartate receptor for its action in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2004;101:8791–8796
  34. Oaklander AL, Romans K, Horasek S, Stocks A, Hauer P, Meyer RA. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol. 1998;44:789–795
  35. Ohashi Y, Guo T, Orii R, Maze M, Fujinaga M. Brain stem opioidergic and GABAergic neurons mediate the antinociceptive effect of nitrous oxide in Fischer rats. Anesthesiology. 2003;99:947–954
  36. Parsons CG. NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol. 2001;429:71–78
  37. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002;25:319–325
  38. Pud D, Eisenberg E, Spitzer A, Adler R, Fried G, Yarnitsky D. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: A double blind, randomized, placebo controlled trial. Pain. 1998;75:349–354
  39. Rabben T, Skjelbred P, Oye I. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther. 1999;289:1060–1066
  40. Ranft A, Kurz J, Becker K, Dodt HU, Zieglgansberger W, Rammes G, et al. Nitrous oxide (N2O) pre- and postsynaptically attenuates NMDA receptor-mediated neurotransmission in the amygdala. Neuropharmacology. 2007;52:716–723
  41. Ren K, Dubner R. Neuron-glia crosstalk gets serious: Role in pain hypersensitivity. Curr Opin Anaesthesiol. 2008;21:570–579
  42. Richebe P, Rivat C, Creton C, Laulin JP, Maurette P, Lemaire M, et al. Nitrous oxide revisited: Evidence for potent antihyperalgesic properties. Anesthesiology. 2005;103:845–854
  43. Richebe P, Rivat C, Laulin JP, Maurette P, Simonnet G. Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats. Anesthesiology. 2005;102:421–428
  44. Rivat C, Laboureyras E, Laulin JP, Le Roy C, Richebe P, Simonnet G. Non-nociceptive environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats. Neuropsychopharmacology. 2007;32:2217–2228
  45. Rivat C, Laulin JP, Corcuff JB, Celerier E, Pain L, Simonnet G. Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: Prevention by the N-methyl-D-aspartate receptor antagonist ketamine. Anesthesiology. 2002;96:381–391
  46. Salter MW. Cellular neuroplasticity mechanisms mediating pain persistence. J Orofac Pain. 2004;18:318–324
  47. Sato Y, Kobayashi E, Murayama T, Mishina M, Seo N. Effect of N-methyl-D-aspartate receptor epsilon1 subunit gene disruption of the action of general anesthetic drugs in mice. Anesthesiology. 2005;102:557–561
  48. Scholz J, Woolf CJ. Can we conquer pain?. Nat Neurosci. 2002;5(Suppl):1062–1067
  49. Sotgiu ML, Biella G. Contribution of central sensitization to the pain-related abnormal activity in neuropathic rats. Somatosens Mot Res. 2000;17:32–38
  50. Watkins LR, Milligan ED, Maier SF. Glial activation: A driving force for pathological pain. Trends Neurosci. 2001;24:450–455
  51. Woolf CJ, Mannion RJ. Neuropathic pain: Aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959–1964
  52. Woolf CJ, Salter MW. Neuronal plasticity: Increasing the gain in pain. Science. 2000;288:1765–1769
  53. Xie W, Strong JA, Meij JT, Zhang JM, Yu L. Neuropathic pain: Early spontaneous afferent activity is the trigger. Pain. 2005;116:243–256
  54. Yamakura T, Lewohl JM, Harris RA. Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels. Anesthesiology. 2001;95:144–153
  55. Yasuda T, Miki S, Yoshinaga N, Senba E. Effects of amitriptyline and gabapentin on bilateral hyperalgesia observed in an animal model of unilateral axotomy. Pain. 2005;115:161–170
  56. Yu LC, Hansson P, Brodda-Jansen G, Theodorsson E, Lundeberg T. Intrathecal CGRP8-37-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation. Br J Pharmacol. 1996;117:43–50

PII: S1526-5900(09)00564-1

doi: 10.1016/j.jpain.2009.05.003

The Journal of Pain
Volume 11, Issue 1 , Pages 13-23 , January 2010

Article Tools

* Image Usage & Resolution